Lucd, the provider of an AI platform that enables organizations to build production-ready AI solutions, today announced its predictive disease spreading model, Avicenna. The model includes more than three billion people worldwide, nearly one-third of the global population, and has maintained 94 percent accuracy during this growth in predicting the spread of the COVID-19 virus 90 days out. Lucd is offering this global pandemic model free to the public.
“We don’t deliver simple projections which are based on historical or incomplete information. With Avicenna, we deliver actual AI-led predictions with an unprecedented understanding of where the disease is today, and where it will be in the future with a high degree of accuracy. For 13 years we have been at the forefront of advising major organizations where viruses will hit and to the extent they should expect their workforces to be impacted. During COVID-19 we predicted the 45 day spread in cities such as New York and Dallas with 95 percent accuracy. Armed with this data, leaders are able to mitigate spread and better understand and prepare for the downstream impact,” said John Leschorn, COO, Lucd.
Lucd began the development of a global pandemic modeling AI after the Avian Flu (H5N1) outbreak in 2006. The model was created in collaboration with the U.S. Center for Disease Control and Prevention, MIT and Rensselaer Polytechnic Institute. The result was the world’s largest-scale capability for modeling infectious disease spread at the person level. Avicenna is an expansion on this original software and was launched in July of 2020 to help organizations prepare for and mitigate the impact of the COVID-19 pandemic.
“With the onset of the coronavirus epidemic we immediately began to work with the Joint AI Center in the U.S. Department of Defense, Health and Human Services, Defense Threat Agency and the U.S. National Guard to provide insights that would have a definitive effect on planning nationwide. Avicenna is built to predict not just disease spread but its impact on commerce and infrastructure. Furthermore, the power of Avicenna is understanding the impact of infectious disease at the most granular level possible. Avicenna results are typically aggregated at the neighborhood, or Census Tract level in the United States. For our enterprise customers, we are able to provide information on their workplace locations, and their workforce community down to the individual,” said Leschorn.
Lucd plans to continually expand the Avicenna platform to include new data sets and new population data to further increase the integrity of results in the short-term and to be able to look at the long-haul effects of COVID-19 in years to come. These insights are expected to have an impact on a variety of industries, including manufacturing, healthcare, pharmaceutical and insurance.
For more information visit https://www.avicenna.lucd.ai/